View our Product Catalog to find products you can try for free.
View our Product Catalog to find products you can try for free.
New Image Soft Convex CeraPlus skin barrier with a unique combination of fit and formulation.
Try It FreeSelecting the Right Ostomy Product Can Make All the Difference
Learn MoreWith 100% No Touch Protection, whatever you touch won't touch VaPro™ catheters
Learn MoreJan Colwell, RN, MSN, CWOCN, Joyce Pittman, PhD, RN, NP, CWOCN, and Rose Raizman, RN-EC, NSWOC(C), M.Sc., MN, were recently honored by the Wound, Ostomy and Continence Nurses (WOCN®) Society™ with the Research Merit Award for their poster on the ADVOCATE Randomized Controlled Trial entitled “Ostomy Skin Barriers and Costs of Care.”
The ADVOCATE study is the first to provide health and economic outcomes data demonstrating that the use of CeraPlus skin barriers could improve skin health and lower the cost of ostomy care. The full study and results can be seen here in the Journal of Wound, Ostomy and Continence Nursing.
“We are thankful for the visionary and innovative leadership demonstrated by the talented team of clinicians who helped design and implement the ADVOCATE Study, including Jan Colwell, Joyce Pittman, and Rose Raizman,” said Brian Luedtke, Senior Vice President, Hollister Incorporated. “We are delighted to see such a high level of peer recognition for the ground-breaking work implemented by these leading clinicians.”
The ADVOCATE poster prevailed over 40 poster submissions in the same category. Each submission went through multiple levels of rigorous reviews. Ten finalists were then evaluated on six levels of criteria by a panel of four wound, ostomy and continence experts to choose the winner.
“I am honored to be involved with these other great co-authors in the dissemination of the ADVOCATE study findings. WOC nurses and clinicians caring for individuals with an ostomy now have strong evidence to make a clinical practice decision regarding the most appropriate skin barrier to decrease cost of ostomy care and to reduce peristomal skin complications,” said Joyce Pitman, ADVOCATE co-author.
“I was thrilled when I heard that the ADVOCATE Study was going to be a randomized double-blinded study in ostomy. Such high level, quality of evidence is hard to find in this space and an honor to be part of.” said Rose Raizman, ADVOCATE co-author.
The prestigious award was presented at the WOCN’s 50th Annual Conference, June 3 – 5, 2018 in Philadelphia, PA.
On October 21, 2024, Crain's Chicago Business released its list of the Most Innovative Companies in ...
Read More
Corporate, Continence, Ostomy, Wound & Skin
Read More
Gill Castle becomes the first person with a stoma to make the swim alone.
Read More
Rachel Stokes, a Hollister ostomy consumer, shares her ostomy journey.
Read More
The 2022 Sustainability Report communicates Hollister‘s progress under the pillars of Environment, S...
Read More
Whether you're a patient, a caregiver, or a healthcare professional, if you have any questions about Hollister products or services, we can help.
Prior to use, be sure to read the Instructions for Use for information regarding Intended Use, Contraindications, Warnings, Precautions, and Instructions.
The information provided herein is not medical advice and is not intended to substitute for the advice of your personal physician or other healthcare provider. This information should not be used to seek help in a medical emergency. If you experience a medical emergency, seek medical treatment in person immediately.
We want to make it as easy as possible for you to navigate our website. Please select your country and preferred language to ensure that you see customized content and accurate product availability information.
Loading content...
Sorry, but we were unable to load this content. Please try again.
You are now leaving the Hollister Incorporated website and are going to a website that is not operated by us. Hollister Incorporated is not responsible for the content on or availability of linked sites. Please be aware that linked sites may have different security or privacy policies.